860.545.9000 | Our Locations

Glycogen Storage Disease Program

The Glycogen Storage Disease Program is the largest clinical and research program for glycogen storage disease (GSD). A joint program between Connecticut Children’s and the University of Connecticut, our mission is to pursue research while providing evidence-based care for children and adults with the disease. We collaborate with centers of expertise worldwide.
Learn more about our services »

Global Experts in Treating GSD

The GSD program is led by globally recognized endocrinologist and researcher, David A. Weinstein, MD, MMSc. More than 500 patients travel from 49 states and 45 countries for his team’s expert care.
Learn more about our team »

Breakthrough Gene Therapy Treatments

Dr. Weinstein is the world’s top researcher for GSD. In 2018, he launched the world’s first human gene therapy clinical trial to treat GSD – an advance 20 years in the making.
Learn more about our research »

Glycogen Storage Disease Program Locations

Glycogen Storage Disease program services are offered at our main campus in Hartford.


Back to Top
Searching Animation